Skip to main content
Loading

Estrigenix Therapeutics, Inc

October 17, 2023
Franciscan B
Oncology
Company Description: Estrigenix Therapeutics is preclinical pharmaceutical development company pioneering therapies to improving women's health. Estrigenix was formed as a spinout of collaborative research on ERbeta selective agonists at 3 Milwaukee area universities. Our focus is on a family of non-steroidal molecules for the treatment of menopause symptoms, but without the risk of breast cancer which is associated with traditional estrogen therapy. We have demonstrated the efficacy of EGX358 for moderating hot flashes and improving memory consolidation in an animal model for menopause. Furthermore EGX358 does not cause the proliferation of MCF-7 cells, the most prevalent cell line of breast cancer.
Speakers
William Donaldson, President & CEO - Estrigenix Therapeutics